4.3 Article

Contemporary Sex-Based Differences by Age in Presenting Characteristics, Use of an Early Invasive Strategy, and Inhospital Mortality in Patients With Non-ST-Segment-Elevation Myocardial Infarction in the United States

期刊

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCINTERVENTIONS.117.005735

关键词

comorbidity; hospitalization; hospital mortality; length of stay; risk factors

资金

  1. Empire Clinical Research Investigator Program
  2. National Institutes of Health/National Center for Advancing Translational Science Einstein-Montefiore CTSA [UL1TR001073]
  3. AHA Mentored Clinical and Population Award
  4. Amarin
  5. Amgen
  6. AstraZeneca
  7. Bristol-Myers Squibb
  8. Chiesi
  9. Eisai
  10. Ethicon
  11. Forest Laboratories
  12. Ironwood
  13. Ischemix
  14. Lilly
  15. Medtronic
  16. Pfizer
  17. Roche
  18. Sanofi Aventis
  19. Medicines Company

向作者/读者索取更多资源

Background-Prior studies have reported higher inhospital mortality in women versus men with non-ST-segment-elevation myocardial infarction. Whether this is because of worse baseline risk profile compared with men or sex-based disparities in treatment is not completely understood. Methods and Results-We queried the 2003 to 2014 National Inpatient Sample databases to identify all hospitalizations in patients aged 18 years with the principal diagnosis of non-ST-segment-elevation myocardial infarction. Complex samples multivariable logistic regression models were used to examine sex differences in use of an early invasive strategy and inhospital mortality. Of 4765739 patients with non-ST-segment-elevation myocardial infarction, 2026285 (42.5%) were women. Women were on average 6 years older than men and had a higher comorbidity burden. Women were less likely to be treated with an early invasive strategy (29.4% versus 39.2%; adjusted odds ratio, 0.92; 95% confidence interval, 0.91-0.94). Women had higher crude inhospital mortality than men (4.7% versus 3.9%; unadjusted odds ratio, 1.22; 95% confidence interval, 1.20-1.25). After adjustment for age (adjusted odds ratio, 0.96; 95% confidence interval, 0.94-0.98) and additionally for comorbidities, other demographics, and hospital characteristics, women had 10% lower odds of inhospital mortality (adjusted odds ratio, 0.90; 95% confidence interval, 0.89-0.92). Further adjustment for differences in the use of an early invasive strategy did not change the association between female sex and lower risk-adjusted inhospital mortality. Conclusions-Although women were less likely to be treated with an early invasive strategy compared with men, the lower use of an early invasive strategy was not responsible for the higher crude inhospital mortality in women, which could be entirely explained by older age and higher comorbidity burden.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据